PROCR and cancer: Characterization of circulating blood EVs isolated from patients with several different cancer types has shown that EVs express active-surface TF and encapsulate several anticoagulant proteins, such as the TF pathway inhibitor (TFPI) and endothelial protein C receptor (EPCR) with pro-coagulant activity [10].